Nasopharyngeal carcinoma incidence and mortality in China in 2009

Chinese Journal of Cancer

Volumn 32, Issue 8, 2013, Pages 453-460

  Xu, Zhi Jian ^a   Zheng, Rong Shou ^b   Zhang, Si Wei ^b   Zou, Xiao Nong ^b   Chen, Wan Qing ^b  

^a CANCER HOSPITAL   (China)

^b National Cancer Center   (China)

Author keywords

Cancer registry; China; Incidence; Mortality; Nasopharyngeal carcinoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CHILD; CHINA; DATA BASE; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; ICD-10; INFORMATION RETRIEVAL; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; POPULATION STRUCTURE; PRESCHOOL CHILD; PRIMARY PREVENTION; RURAL AREA; SCHOOL CHILD; SECONDARY PREVENTION; SEX DIFFERENCE; URBAN AREA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; REGISTRIES; RURAL POPULATION; SEX FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 84881270200     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.013.10118     Document Type: Article

References (22)

1. Huang TR, Zhang SW, Chen WQ, et al. Trends in nasopharyngeal carcinoma mortality in China, 1973-2005. Asian Pac J Cancer Prev, 2012,13:2495-2502.
2. Black RJ, Bray F, Ferlay J, et al. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer, 1997,33:1075-1107.
3. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol, 2002,12:421-429.
4. Ren JS, Chen WQ, Shin HR, et al. A comparison of two methods to estimate the cancer incidence and mortality burden in China in 2005. Asian Pac J Cancer Prev, 2010,11:1587-1594.
5. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 2006,15:1765-1777.
6. Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer, 2011,30:114-119.
7. Yang WS, Yang C, Zheng JW, et al. Time trend analysis of incidence rate for nasopharyngeal carcinoma in urban Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi, 2009,30:1171-1174. [in Chinese]
8. National Office for Cancer Prevention and Control & National Central Cancer Registry. The guideline of Chinese cancer registration. Beijing: The Peking Union Medical College Press, 2004. [in Chinese]
9. [Cancer incidence in five continents. Volume IX. IARC Sci Publ, 2008:1-837.
10. Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, vol. LX. Lyon: IARC, Scientific Publications No. 160, 2007.
11. Parkin DM. Comparability and quality control in cancer registration. Lyon: IARC, 1994.
12. Ferlay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. Lyon: IARC, 2005.
13. [National Office for Cancer Prevention and Control, National Center for Cancer Registry, Disease Prevnetion and Control Bureau, MOH. Chinese cancer registry annual report (2010). Beijing: Military Medical Science Press, 2011:2.
14. Xie SH, Gong J, Yang NN, et al. Time trends and age-period-cohort analyses on incidence rates of nasopharyngeal carcinoma during 1993-2007 in Wuhan, China. Cancer Epidemiol, 2012,36:8-10.
15. Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer, 2006,6:178.
16. Arnold M, Wildeman MA, Visser O, et al. Lower mortality from nasopharyngeal cancer in the netherlands since 1970 with differential incidence trends in histopathology. Oral Oncol, 2013,49:237-243.
17. Ng WT, Choi CW, Lee MC, et al. Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong. Fam Cancer, 2010,9:221-228.
18. Rao DP, Liu Q, Cao SM. Cost-effectiveness evaluation of seven screening strategies for nasopharyngeal carcinoma. Zhonghua Zhong Liu Za Zhi, 2012,34:549-553. [in Chinese]
19. Liu Y, Huang Q, Liu W, et al. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China. Int J Cancer, 2012,131:406-416.
20. Chen F, Huang QH, Fang F, et al. Interval cancers in nasopharyngeal carcinoma screening: comparing two screening intervals after a negative initial screening result. J Med Screen, 2012,19:195-200.
21. Cao SM, Liu Z, Jia WH, et al. Fluctuations of Epstein-Barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up. PLoS One, 2011,6:e19100.
22. Chan KC, Hung EC, Woo JK, et al. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program. Cancer, 2013,119:1838-1844.